Acceptability of a new 4-in-1 Abacavir/Lamivudine/Lopinavir/Ritonavir paediatric fixed-dose combination: the caregiver-child dyads' perspective.

Rotsaert AnkeCollin OgaraJuliet Mwanga-AmumpaireAdeodata R KekitiinwaVictor MusiimeElizabeth NajjingoGrace P KisituRashidah NazzindaEsther NambiJanice LeeMariama DialloFlavia KyomuhendoMoses WaweruIsabelle Andrieux-MeyerChristiana Nöstlinger

Published in: Therapeutic advances in infectious disease (2023)

Clinical trial number: NCT03836833.

Keyphrases

clinical trial
hiv infected patients
intensive care unit
antiretroviral therapy
mental health
emergency department
phase ii
open label
study protocol
double blind
phase iii